Skip to content

Patients › General-Health

手、腕和手指上的肿块和隆起

Found a lump on your hand, wrist or finger? The common causes and what they mean: ganglion cysts, fatty lumps (lipomas), giant cell tumours, mucous cysts and carpal bossing, and when to see someone.

Updated Aug 2026
手腕背面有一个光滑圆形的腱鞘囊肿。
大多数手部和腕部的肿块是良性的。腱鞘囊肿是最常见的,但任何新出现的肿块都值得检查。 Kieran Hirpara 4.0

本页面由机器翻译,尚未经临床医生审核。英文版本为权威版本。

您的感受

您可能会注意到手腕背侧有一个小肿块。这通常是一个充满液体的囊,称为腱鞘囊肿。它摸起来可能较硬或有弹性。部分患者在该区域感到疼痛,尤其是当肿块压迫邻近的神经或关节时。当您弯曲手腕或将重量施加于手部时,疼痛可能会加重。在进行打字、提购物袋或做家务等活动后,您可能会感到钝痛。

如果肿块位于手腕掌侧,您可能会感到紧绷或不适。这可能导致您难以牢固地抓握物体。您可能会发现日常活动变得困难。例如,转动门把手或握住咖啡杯可能会感觉别扭或疼痛。在某些情况下,肿块本身无痛,但因其大小或外观而令人烦恼。

十岁以下儿童常在手腕掌侧出现此类肿块。在这种情况下,肿块通常会自行消退。约 69% 至 79% 的儿童期肿块会在 12 至 18 个月内未经治疗自行消失。如果是成年人,肿块可能会持续更长时间。它可能会时隐时现。有时它会缩小,但随后又复发。

您可能还会注意到手指上有一个小凸起。这可能是不同类型的生长物,例如脂肪瘤(一种良性的脂肪肿块)。这些肿块通常质地柔软,可在皮下轻微移动。除非压迫到敏感结构,否则它们很少引起疼痛。然而,任何新出现的肿块都应由您的外科医生进行检查,以排除更严重的疾病。

疼痛程度可能有所不同。如果您长期受此问题困扰,或肿块位于优势手,术后您可能会感到更多不适。这是正常的。您的外科医生将讨论管理疼痛的方法。请记住,目标是帮助您无痛地恢复日常活动。无论是伸手到背后扣内衣扣子,还是将衬衫塞进裤子里,您都希望手部功能顺畅。您的外科医生将根据您的具体情况指导您选择最佳方案。

实际情况是什么

腱鞘囊肿是一种形成于关节或肌腱附近的充满液体的囊袋。可以把它想象成一个小水球。它通常出现在手腕背侧或手掌侧。囊内的液体呈浓稠的果冻状,类似于保持关节平滑运动的润滑液。当多余的液体从关节囊(包裹关节的坚韧套筒)渗漏出来时,这个囊袋就会增大。

这些肿块通常是无害的,但可能会带来困扰。它们可能会引起疼痛,或导致手腕或手指弯曲困难。在某些情况下,肿块会压迫附近的神经或肌腱。正是这种压力导致了您感受到的不适或无力。您的外科医生会检查该区域,以确定肿块是腱鞘囊肿、扳机指还是其他类型的结节。仔细的体格检查有助于区分这些常见疾病。

在10岁以下的儿童中,这些肿块通常出现在手腕掌侧。好消息是,它们经常自行消退。约69%至79%的儿童腱鞘囊肿会在12至18个月内自行消失,无需手术。对于成年人,身体自然消除问题的可能性较小。如果肿块持续存在,您的外科医生可能会建议首先用针头抽吸。这一步骤可以在考虑更具侵入性的治疗方案之前,帮助控制费用和症状。

手或手指上的其他肿块可能是称为脂肪瘤的实心脂肪增生。这些是由脂肪组织构成的良性肿瘤。它们通常质地柔软,在皮肤下可轻微移动。与腱鞘囊肿不同,它们不含液体。手指上的大多数脂肪瘤都很小,不会引起任何问题。然而,如果它们长得很大或变得疼痛,您的外科医生可能会建议将其切除。简单的切除通常能带来良好的结果,在短期至中期不会复发。

了解这些肿块的性质有助于您做出明智的决定。有些需要观察等待,而另一些则需要干预。您的外科医生将根据肿块的具体类型及其对日常生活的影响为您提供指导。

预期情况

您的预后主要取决于肿块的位置以及您的年龄。如果您是一名10岁以下的儿童,总体情况通常非常乐观。该年龄段患者的腱鞘囊肿多出现在腕部掌侧。它们常可自行消退。在12至18个月内,69%至79%的此类肿块无需任何治疗即可消失。您的外科医生可能会建议先观察一段时间。

对于成年人,病程则有所不同。腕背侧的腱鞘囊肿自发消退的可能性较小。若不予处理,它们可能持续存在或反复发作。腕背侧开放手术的复发率较高,意味着肿块常会复发。这就是为什么您的外科医生可能会先讨论其他治疗方案。

如果您选择积极治疗,总体预后通常良好。对于手指上的囊肿,单纯切除通常在短中期能获得良好效果,且肿块不复发。对于腕部腱鞘囊肿,您的外科医生可能会建议在考虑手术前先通过针头抽吸囊液。这一步骤可以有效控制费用并缓解症状。

每个人的恢复感受各不相同。如果患者既往接受过手术、症状持续时间较长,或受累手为优势手,治疗后疼痛程度可能较高。您的外科医生将讨论如何管理这种不适。

需要明确的是,并发症虽罕见但有可能发生。如果您的腱鞘囊肿位于腕部掌侧特定血管附近,治疗期间出现问题的风险会略高。您的外科医生会仔细检查您的手部,以规划最安全的治疗方案。

总体而言,手部和腕部的多数肿块均可管理。无论您选择等待其自行缓解还是接受治疗,您的外科医生都旨在实现明确的治疗效果。随着患处愈合,您可以预期逐渐恢复正常活动。


Evidence & references

This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.

Overview

  • Distinguishing between a flexor sheath ganglion, trigger digit, and Dupuytren's nodule may be accomplished with a detailed physical examination of the MCP region of the affected digit [1].
  • In children aged <10 years, ganglions mainly occur on the volar wrist [3].
  • Pediatric ganglions of the hand have a greater rate of resolution than ganglions of the wrist [5].
  • 69% to 79% of pediatric ganglions in children aged <10 years display spontaneous regression within a span of 12-18 months [3].
  • Cystic soft tissue tumours of the dorsal aspect of the wrist have two distinct histological subtypes [7].
  • Open surgery continues to be an ineffective way of managing cystic soft tumours of the dorsal aspect of the wrist due to high recurrence rates [7].
  • Arthroscopic resection of dorsal wrist ganglions with midcarpal exploration appeared to reduce recurrence at 1 year without negatively impacting patient outcomes [6].
  • Routine midcarpal joint exploration during arthroscopic excision of dorsal wrist ganglions appeared to reduce recurrence at 1 year without negatively impacting patient outcomes [6].
  • Higher postoperative pain intensity was associated with recurrence following previous surgery [8].
  • Higher postoperative pain intensity was associated with treatment of the dominant hand [8].
  • Higher postoperative pain intensity was associated with higher baseline pain intensity [8].
  • Higher postoperative pain intensity was associated with lower credibility the patient attributes to the treatment [8].
  • Higher postoperative pain intensity was associated with longer symptom duration [8].
  • Hand surgeons are divided regarding the need to immobilize the wrist after dorsal wrist ganglion excision [4].
  • Performing at least 1 aspiration before surgical excision improves the cost-effectiveness of dorsal wrist ganglions treatment [2].
  • Giant cell tumors of the distal phalanx are extremely rare [9].
  • Giant cell tumors of the distal phalanx require extensive en bloc excision to prevent local recurrence [9].
  • Digit-sparing operations for giant cell tumors of the distal phalanx may fail to eradicate all tumor foci [9].
  • A giant spindle cell lipoma can involve a finger, representing an unusual location for this rare variant [10].
  • Marginal excision appears to result in a good outcome with no recurrence at short- to medium-term follow-up for parosteal lipomas of the phalanges [12].
  • Awareness of anatomic variations, such as a persistent median artery with a reversed palmaris longus and volar ganglion, is valuable for surgeons operating on the upper extremity [11].

Background & Causes

  • Giant spindle cell lipoma involving a finger represents an unusual location for a rare variant of giant lipoma [10].
  • A persistent median artery with a reversed palmaris longus and volar ganglion represents an anatomic variation in the upper extremity [11].
  • Parosteal lipomas can occur in the proximal phalanx of the hand [12].
  • An angiolipoma of the hand can cause carpal tunnel syndrome [13].

Management

Diagnosis and Physical Examination

  • Distinguishing between a flexor sheath ganglion, trigger digit, and Dupuytren's nodule can be accomplished with a detailed physical examination of the MCP region of the affected digit [1].

Non-Operative Management

  • In children aged <10 years, ganglions mainly occur on the volar wrist and can be treated expectantly, with 69% to 79% displaying spontaneous regression within a span of 12-18 months [3].
  • Performing at least 1 aspiration before surgical excision improves the cost-effectiveness of dorsal wrist ganglion treatment, as patient preferences may preclude routinely performing 2 aspirations [2].
  • There is no difference in reintervention at 1-year between ultrasound-guided versus blind dorsal carpal ganglion aspiration [16].
  • Patients who received steroids at the time of aspiration perceived lower rates of recurrence [16].
  • Scar massage is widely used as an intervention for post-surgical scars, though few therapists have received formal skills training or completed outcome measures regularly to formally evaluate its clinical efficacy or impact [14].

Operative Management

  • Giant cell tumors of the distal phalanx require extensive en bloc excision to prevent local recurrence, as digit-sparing operations may fail to eradicate all tumor foci [9].
  • Both curettage and resection/amputation are acceptable treatment options for giant cell tumour of bone in the hand, with treatment decisions needing to be individualized based on the site and extent of disease to minimize treatment morbidity while maximizing disease control [17].

Postoperative Outcomes

  • Higher postoperative pain intensity was associated with recurrence following previous surgery, treatment of the dominant hand, higher baseline pain intensity, lower credibility the patient attributes to the treatment and longer symptom duration [8].

Key Considerations

  • Performing at least 1 aspiration before surgical excision improves the cost-effectiveness of dorsal wrist ganglion treatment when patient preferences preclude routinely performing 2 aspirations [2].
  • Open surgery continues to be an ineffective way of managing cystic soft tissue tumors of the dorsal aspect of the wrist due to high recurrence rates [7].
  • Giant cell tumors of the distal phalanx are extremely rare and require extensive en bloc excision to prevent local recurrence, as digit-sparing operations may fail to eradicate all tumor foci [9].
  • Resection followed by wrist arthrodesis and structural iliac bone graft achieved satisfactory oncologic and functional results for giant cell tumor of bone, albeit with one-third of all patients experiencing some complications at a minimum of 10 years of follow-up [15].

Key Evidence

  • [L4] Distinguishing between a flexor sheath ganglion, trigger digit, and Dupuytren's may be accomplished with a detailed physical examination of the MCP region of the affected digit. [1] (10.1177/15589447221109644)
  • [L2] As patient preferences may preclude routinely performing 2 aspirations, performing at least 1 aspiration before surgical excision improves the cost-effectiveness of dorsal wrist ganglions treatment. [2] (10.1016/j.jhsa.2022.09.002)
  • [L4] In children aged <10 years, ganglions mainly occur on the volar wrist and can be treated expectantly, with 69% to 79% displaying spontaneous regression within a span of 12-18 months. [3] (10.1016/j.jhsa.2021.12.015)
  • [L2] The systematic review and survey of Canadian hand surgeons reveal that hand surgeons are divided regarding the need to immobilize the wrist after dorsal wrist ganglion excision. [4] (10.1177/15589447211014631)
  • [L4] Pediatric ganglions of the hand have a greater rate of resolution than ganglions of the wrist. [5] (10.1016/j.jhsa.2023.07.002)
  • [L3] Routine midcarpal joint exploration during arthroscopic excision of dorsal wrist ganglions appeared to reduce recurrence at 1 year without negatively impacting patient outcomes. [6] (10.1177/17531934251405730)
  • [L4] The authors suggest that open surgery continues to be an ineffective way of managing cystic soft tumours of the dorsal aspect of the wrist due to high recurrence rates. [7] (10.1177/17531934241251721)
  • [L2] Higher postoperative pain intensity was associated with recurrence following previous surgery, treatment of the dominant hand, higher baseline pain intensity, lower credibility the patient attributes to the treatment and longer symptom duration. [8] (10.1177/17531934231153029)
  • [L4] Giant cell tumors of the distal phalanx are extremely rare and require extensive en bloc excision to prevent local recurrence, as digit-sparing operations may fail to eradicate all tumor foci. [9] (10.1016/j.jhsa.2020.04.005)
  • [Case_report] The case is reported due to the unusual location of a rare variant of giant lipoma involving a finger. [10] (10.1055/s-0040-1721879)
  • [L4] Awareness of such anatomic variations is valuable for surgeons operating on the upper extremity. [11] (10.1016/j.jhsg.2022.04.005)
  • [L4] Marginal excision appears to result in a good outcome with no recurrence at short- to medium-term follow-up for parosteal lipomas of the phalanges. [12] (10.1016/j.jhsa.2020.10.029)
  • [L4] This case is the first report of an angiolipoma as a cause of carpal tunnel syndrome. [13] (10.1016/j.jhsg.2022.05.006)
  • [L4] Whilst scar massage was widely used, few respondents had received formal skills training or completed outcome measures regularly to formally evaluate its clinical efficacy or impact. [14] (10.1177/17589983231205666)
  • [L2] Resection followed by wrist arthrodesis and structural iliac bone graft achieved satisfactory oncologic and functional results, albeit with one-third of all patients experiencing some complications at a minimum of 10 years of follow-up. [15] (10.1097/corr.0000000000003738)
  • [L3] Patients who received steroids at the time of aspiration perceived lower rates of recurrence. [16] (10.1016/j.jhsg.2023.06.007)
  • [L4] Both curettage and resection/amputation are acceptable treatment options for the rare condition of giant cell tumour of bone in the hand, with a need to individualize treatment decisions based on the site and extent of disease to minimize treatment morbidity while maximizing disease control. [17] (10.1177/17531934211007820)

References

[1] A Simple Physical Exam Maneuver to Distinguish Trigger Digit, Dupuytren’s Nodule, and Flexor Sheath Ganglion. HAND. 2022. DOI: 10.1177/15589447221109644

[2] Minimizing Costs for Dorsal Wrist Ganglion Treatment: A Cost-Minimization Analysis. The Journal of Hand Surgery. 2023. DOI: 10.1016/j.jhsa.2022.09.002

[3] Pediatric Ganglions of the Hand and Wrist: A Review of Current Literature. The Journal of Hand Surgery. 2022. DOI: 10.1016/j.jhsa.2021.12.015

[4] Immobilization of the Wrist After Dorsal Wrist Ganglion Excision: A Systematic Review and Survey of Current Practice. HAND. 2021. DOI: 10.1177/15589447211014631

[5] Natural History of Pediatric Hand and Wrist Ganglion Cysts: Longitudinal Follow-Up of a Prospective, Dual-Center Cohort. The Journal of Hand Surgery. 2023. DOI: 10.1016/j.jhsa.2023.07.002

[6] Arthroscopic resection of dorsal wrist ganglions with or without midcarpal exploration. Journal of Hand Surgery (European Volume). 2025. DOI: 10.1177/17531934251405730

[7] Cystic soft tissue tumours of the dorsal aspect of the wrist have two distinct histological subtypes. Journal of Hand Surgery (European Volume). 2024. DOI: 10.1177/17531934241251721

[8] Factors associated with self-reported pain and hand function following dorsal wrist ganglion excision. Journal of Hand Surgery (European Volume). 2023. DOI: 10.1177/17531934231153029

[9] Giant Cell Tumor of the Ring Finger Distal Phalanx. The Journal of Hand Surgery. 2021. DOI: 10.1016/j.jhsa.2020.04.005

[10] Giant Spindle Cell Lipoma of Middle Finger: Case Report and Review of Literature. Journal of Hand and Microsurgery. 2024. DOI: 10.1055/s-0040-1721879

[11] Persistent Median Artery With a Reversed Palmaris Longus and Volar Ganglion. Journal of Hand Surgery Global Online. 2022. DOI: 10.1016/j.jhsg.2022.04.005

[12] Parosteal Lipoma of the Proximal Phalanx of Hand. The Journal of Hand Surgery. 2021. DOI: 10.1016/j.jhsa.2020.10.029

[13] Large Angiolipoma of the Hand as a Cause for Carpal Tunnel Syndrome. Journal of Hand Surgery Global Online. 2022. DOI: 10.1016/j.jhsg.2022.05.006

[14] Scar massage as an intervention for post-surgical scars: A practice survey of Australian hand therapists. Hand Therapy. 2023. DOI: 10.1177/17589983231205666

[15] What Are the Long-term Outcomes of Wrist Arthrodesis Using Structural Iliac Bone Graft After Resection of the Distal Radius for Giant Cell Tumor of Bone? A Minimum 10-year Follow-up. Clinical Orthopaedics & Related Research. 2025. DOI: 10.1097/corr.0000000000003738

[16] No Difference in Reintervention at 1-Year Between Ultrasound-Guided versus Blind Dorsal Carpal Ganglion Aspiration. Journal of Hand Surgery Global Online. 2023. DOI: 10.1016/j.jhsg.2023.06.007

[17] Giant cell tumour of hand bones: outcomes of treatment. Journal of Hand Surgery (European Volume). 2021. DOI: 10.1177/17531934211007820

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International


Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees


Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.


Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.